已收盘 12-19 16:00:00 美东时间
0.000
0.00%
Vivos Therapeutics acquires The Sleep Center of Nevada, expanding its OSA diagnostic and treatment capabilities, completing its business model shift, and securing $11M in financing. The deal enhances Vivos' access to high patient volumes and higher-margin revenues.
06-11 12:30
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaini...
2024-09-20 02:57
U.S. stocks traded higher midway through trading, with the Dow Jones index jump...
2024-09-20 00:39
Vivos Therapeutics shares are trading lower by 25% Thursday morning. The company announced a $4.3 million registered offering.
2024-09-19 22:37
U.S. stocks traded higher this morning, with the Nasdaq Composite surging more ...
2024-09-19 21:40
NVDA, TMUS, VVOS, SOFI, TSLA are the top trending stocks on Wednesday.
2024-09-19 11:09
Vivos' DNA appliance now approved to reduce snoring and treat moderate to severe OSA in children aged 6 to 17
2024-09-18 19:02
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and raises the price target from $6.4 to $6.6.
2024-08-20 17:33